Craft

Zevra Therapeutics

Stock Price

$8.3

2024-10-29

Market Capitalization

$434.6 M

2024-10-29

Zevra Therapeutics Summary

Company Summary

Overview
Zevra Therapeutics is a pharmaceutical company that specializes in drug development solutions. It focuses on developing therapies to treat rare diseases such as Niemann-Pick disease type C (NPC), idiopathic hypersomnia (IH), etc.
Type
Public
Status
Active
Founded
2006
Website
https://zevra.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu